Accelerating Biomedical Research Act

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;HR 4662 School-Based Asthma Management Program Act; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; HR 2028 Further Continuing and Security Assistance Appropriations Act, 2017; Issues related to research at the National Institutes of Health; Issues related to Moonshot Initiative; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; H.R.5912 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016;; HR 4662 School-Based Asthma Management Program Act; H.R. 4768, the Separation of Powers Restoration Act of 2016; HR 5263 Women and Lung Cancer Research and Preventive Services Act of 2016; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; HR 2028 Further Continuing and Security Assistance Appropriations Act, 2017; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) FY2017 Agriculture Appropriations (H.R.5054/S.2956) FY2017 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ, NIH,and Education(S.3040/H.R.5926) FY2017 Milcon-VA Appropriations-telestroke(S.2806/H.R.2577) FY2017 Transportation/HUD Approps (air ambulance amendment) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) National Biomedical Research Act (S.2624) National Defense Authorization Act for FY 2017(S.2943) Research for All Act(H.R.2101) Senate Innovations Bill Continuing Resolution (H.R.2028)(P.L.114-254)

Client expense: $175,017 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill. H.R. 34, 21st Century Cures Act.

Client expense: $147,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill. H.R. 34, 21st Century Cures Act.

Client expense: $168,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill. H.R. 34, 21st Century Cures Act.

Client expense: $168,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Labor - HHS Appropriations FY'17 - NIH Financial Aid, Department of Education, Commerce, Justice, Science Appropriations FY'17 - NSF Funds, NASA Funding S289 American Cures Act S318; HR531 Accelerating Biomedical Research Act American Innovation Act H.J. Res59 Bipartisan Budget Act of 2013 Budget Control Act of 2011 - Sequestration Provisions FY'17 Continuing Resolution Energy and Water Appropriations FY'17 - DOE Science Funding Defense Appropriations FY'17 - DOD Research Foreign Operations Appropriations - FY'17

Client expense: $60,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE

FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration, including Continuing Resolution S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act

Client expense: $169,982 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;HR 4662 School-Based Asthma Management Program Act; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; Issues related to research at the National Institutes of Health; Issues related to Moonshot Initiative; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; H.R.5912 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 2577 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; HR 4974 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016; H.R.5325 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act; HR 4662 School-Based Asthma Management Program Act; H.R. 4768, the Separation of Powers Restoration Act of 2016; HR 5263 Women and Lung Cancer Research and Preventive Services Act of 2016; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

S.289/ H.R.2104 - American Cures Act H.R. 6 - 21st Century Cures Act S.2624 - National Biomedical Research Act S. 318/H.R. 531 - Accelerating Biomedical Research Act S. 747/H.R. 1398 - American Innovation Act General National Institutes of Health, National Science Foundation, and BRAIN Initiative FY17 budget and appropriation levels, including continuing resolution and omnibus appropriations.

Client expense: $52,899 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

Presidents Budget, FY 2017 S. 3040/H.R. 5916 Labor, HHS, Education and Related Agencies Act, 2017, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose rescissions from the Center for Medicare and Medicaid Innovation and Patient Centered Outcomes Research Trust Fund. President's Budget, FY 2017 Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy. President's Budget, FY 2017 P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issues: Support funding for Veterans Affairs medical research, research infrastructure, and community care. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. S. 2624, National Biomedical Research Act. Issue: Support establishment of a Biomedical Innovation Fund to support the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. P.L. 114-74, H.R. 1314, Bipartisan Budget Act of 2015 Issue: Oppose Medicare site-neutral payment policy. Oppose extension of Medicare sequester Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issue: Support supplemental funding to prevent and combat Zika virus; Oppose use of other health funding to offset Zika investments

Client expense: $595,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) FY2016 Agriculture Appropriations (S.1800/ H.R.3049) FY2017 Agriculture Appropriations (H.R.5054/S.2956) FY2017 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ, NIH,and Education(S.3040/H.R.5926) FY2017 Milcon-VA Appropriations-telestroke(S.2806/H.R.2577) FY2017 Transportation/HUD Approps (air ambulance amendment) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) National Biomedical Research Act (S.2624) National Defense Authorization Act for FY 2017(S.2943) Research for All Act(H.R.2101) Senate Innovations Bill

Client expense: $166,728 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding of federally-sponsored research Congressional oversight of federally-sponsored research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Labor - HHS Appropriations FY'17 - NIH Financial Aid, Department of Education, Commerce, Justice, Science Appropriations FY'17 - NSF Funds, NASA Funding S289 American Cures Act S318; HR531 Accelerating Biomedical Research Act American Innovation Act H.J. Res59 Bipartisan Budget Act of 2013 Budget Control Act of 2011 - Sequestration Provisions FY'17 Continuing Resolution Energy and Water Appropriations FY'17 - DOE Science Funding Defense Appropriations FY'17 - DOD Research Foreign Operations Appropriations - FY'17

Client expense: $60,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill.

Client expense: $177,513 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill.

Client expense: $176,233 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Accelerating Biomedical Research Act (S. 318/H.R. 531), 21st Century Cures Act (H.R. 6), Senate HELP Committee Innovation for Healthier Americans initiative and other legislative proposals pertinent to NIH policy.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research, education and prevention funding at the National Institutes of Health, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality under the Labor, Health and Human Services, and Education Appropriations legislation (S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017) Advocate for maintain funding as well as application processes in the Department of Defense medical research programs. Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act).

Client expense: $400,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) FY2016 Agriculture Appropriations (S.1800/ H.R.3049) FY2017 Agriculture Appropriations (H.R.5054/S.2956) FY2017 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ, NIH,and Education(S.3040) FY2017 Milcon-VA Appropriations (telestroke) FY2017 Transportation/HUD Approps (air ambulance amendment) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) National Biomedical Research Act (S.2624) National Defense Authorization Act for FY 2017(S.2943) Research for All Act(H.R.2101) Senate Innovations Bill

Client expense: $159,620 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to the House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Issues related to the House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 2577 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; HR 4974 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016; H. Res. 717 National Cancer Research Month; S. Res. 459, National Cancer Research Month; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to the House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill.

Client expense: $157,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act

Client expense: $92,141 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Presidents Budget, FY 2017 S.3040/draft House Labor, HHS, Education and Related Agencies Act, 2017, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose rescissions from the Center for Medicare and Medicaid Innovation and Patient Centered Outcomes Research Trust Fund. President's Budget, FY 2017 Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy. President's Budget, FY 2017 H.R. 2577/H.R. 4974/S. 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and community care. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. S. 2624, National Biomedical Research Act. Issue: Support establishment of a Biomedical Innovation Fund to support the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. P.L. 114-74, H.R. 1314, Bipartisan Budget Act of 2015 Issue: Oppose Medicare site-neutral payment policy. Oppose extension of Medicare sequester Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Issue: Support supplemental funding to prevent and combat Zika virus; Oppose use of other health funding to offset Zika investments

Client expense: $736,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding of federally-sponsored research Congressional oversight of federally-sponsored research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research HR639 Improving Regulatory Transparency for New Medical Therapies Act (signed into law) HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015 (signed into law) HR 2646 S1945 Helping Families in Mental Health Crisis Act of 2015 HR 3731, S 2030 Rare Disease Fund Act of 2015 HR 3729 Limit Fetal Tissue Research S 2141 Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 or TRUST It Act (with respect to health information technology) S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2512 Adding Zika Virus to the FDA Priority Review Voucher Program Act S 1101 Medical Electronic Data Technology Enhancement for Consumers' Health Act S 1767 Combination Product Regulatory Fairness Act of 2015 S 1597 Patient-Focused Impact Assessment Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1945 Mental Health Reform Act of 2015 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2700 FDA and NIH Workforce Authorities Modernization Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers)

Client expense: $15,681 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Accelerating Biomedical Research Act (S. 318/H.R. 531), 21st Century Cures Act (H.R. 6), Senate HELP Committee Innovation for Healthier Americans initiative and other legislative proposals pertinent to NIH policy. American Innovation & Competitiveness Act (S.3084) Commercializing on Small Business Innovation Act of 2016(H.R. 4783) opposing increase in SBIR set aside.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Labor - HHS Appropriations FY'17 - NIH Financial Aid, Department of Education, Commerce, Justice, Science Appropriations FY'17 - NSF Funds, NASA Funding S289 American Cures Act S318; HR531 Accelerating Biomedical Research Act American Innovation Act H.J. Res59 Bipartisan Budget Act of 2013 Budget Control Act of 2011 - Sequestration Provisions Energy and Water Appropriations FY'17 - DOE Science Funding Defense Appropriations FY'17 - DOD Research Foreign Operations Appropriations - FY'17

Client expense: $60,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE

S.289/ H.R.2104 - American Cures Act H.R. 6 - 21st Century Cures Act S.2624 - National Biomedical Research Act S. 318/H.R. 531 - Accelerating Biomedical Research Act S. 747/H.R. 1398 - American Innovation Act General National Institutes of Health, National Science Foundation, and BRAIN Initiative FY16 budget and appropriation levels.

Client expense: $52,444 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; Issues related to Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; Issues related to Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; Issues related to Commerce, Justice, Science, and Related Agencies Appropriations; Issues related to Defense Appropriations; Issues related to Labor, Health and Human Services, Education, and Related Agencies Appropriations; Issues related to Interior, Environment, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs and Related Agencies Appropriations; Issues related to State, Foreign Operations, and Related Programs Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act; HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Implementation of H.R. 3590, the Patient Protection and Affordable Care Act. S. 318/H.R. 531, Accelerating Biomedical Research Act. S. 289, the American Cures Act. Ebola funding. S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, NIH funding. Opioid funding, issues related to veterans employment and mental health

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding of federally-sponsored research Congressional oversight of federally-sponsored research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH S. 2624, "National Biomedical Research Act"

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Presidents Budget, FY 2017 P.L. 114-113, Consolidated Appropriations Act, 2016, Division H, Title II Draft House and Senate Labor, HHS, Education and Related Agencies Act, 2017, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. President's Budget, FY 2017 Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy. President's Budget, FY 2017 Draft House and Senate Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. S. 2624, National Biomedical Research Act. Issue: Support establishment of a Biomedical Innovation Fund to support the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. P.L. 114-74, H.R. 1314, Bipartisan Budget Act of 2015 Issue: Oppose Medicare site-neutral payment policy. Oppose extension of Medicare sequester Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Issue: Support supplemental funding to prevent and combat Zika virus.

Client expense: $822,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

S 318, HR 531 Accelerating Biomedical Research Act HR 744, S 320 Medical Innovation Act (Swear Jar bill) HR 777 Permanent Investment in Health Research Act HR 6 21st Century Cures S 289, HR 2104 American Cures Act HR 2101 Research for All Act S 1077 Advancing Breakthrough Devices for Patients HR 2337 To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices HR 160 Protect Medical Innovation Act of 2015 (to repeal the ACA medical device tax) S2014 HR3466 Next Generation Researchers Act HR 3171 HR 3215 HR 3429 S 1917 legislation relating to the regulation of fetal tissue research HR639 Improving Regulatory Transparency for New Medical Therapies Act (signed into law) HR 2820 Stem Cell Therapeutic and Research Reauthorization Act of 2015 (signed into law) HR 2646 S1945 Helping Families in Mental Health Crisis Act of 2015 HR 3731, S 2030 Rare Disease Fund Act of 2015 HR 3729 Limit Fetal Tissue Research S 2141 Transparent Ratings on Usability and Security to Transform Information Technology Act of 2015 or TRUST It Act (with respect to health information technology) S 2624 National Biomedical Research Act S 1878 Advancing Hope Act of 2015 S 2512 Adding Zika Virus to the FDA Priority Review Voucher Program Act S 1101 Medical Electronic Data Technology Enhancement for Consumers' Health Act S 1767 Combination Product Regulatory Fairness Act of 2015 S 1597 Patient-Focused Impact Assessment Act of 2015 S 2055 Medical Countermeasure Innovation Act of 2016 S 1945 Mental Health Reform Act of 2015 S 1622 FDA Device Accountability Act S 849 Advancing Research for Neurological Diseases Act of 2015 S 800 Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act S 2700 FDA and NIH Workforce Authorities Modernization Act S 2713 Advancing Precision Medicine Act of 2016 S 2745 NIH Strategic Plan and Inclusion in Clinical Research S 2472 Promoting Biomedical Research and Public Health for Patients Act (to reduce regulatory burden on NIH-funded researchers)

Client expense: $36,139 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration (FY 17 Labor/HHS/Education Appropriations and FY 17 Agriculture Appropriations bills). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act)

Client expense: $444,057 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act

Client expense: $98,340 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE